192 related articles for article (PubMed ID: 38051374)
1. Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study.
Kosałka-Węgiel J; Lichołai S; Pacholczak-Madej R; Dziedzina S; Milewski M; Kuszmiersz P; Korona A; Gąsior J; Matyja-Bednarczyk A; Kwiatkowska H; Zaręba L; Siwiec-Koźlik A; Koźlik-Siwiec P; Wach A; Pociej-Marciak W; Sanak M; Musiał J; Bazan-Socha S; Korkosz M
Rheumatol Int; 2024 Jan; 44(1):119-128. PubMed ID: 38051374
[TBL] [Abstract][Full Text] [Related]
2. Genetic Association between TNFA Polymorphisms (rs1799964 and rs361525) and Susceptibility to Cancer in Systemic Sclerosis.
Kosałka-Węgiel J; Lichołai S; Dziedzina S; Milewski M; Kuszmiersz P; Rams A; Gąsior J; Matyja-Bednarczyk A; Kwiatkowska H; Korkosz M; Siwiec A; Koźlik P; Padjas A; Sydor W; Dropiński J; Sanak M; Musiał J; Bazan-Socha S
Life (Basel); 2022 May; 12(5):. PubMed ID: 35629365
[TBL] [Abstract][Full Text] [Related]
3. Association between clinical features and course of systemic sclerosis and serum interleukin-8, vascular endothelial growth factor, basic fibroblast growth factor, and interferon alpha.
Kosałka-Węgiel J; Lichołai S; Dziedzina S; Milewski M; Kuszmiersz P; Korona A; Korkosz M; Gąsior J; Matyja-Bednarczyk A; Kwiatkowska H; Siwiec-Koźlik A; Sydor W; Wilańska J; Zaręba L; Pociej-Marciak W; Dropiński J; Sanak M; Musiał J; Bazan-Socha S
Adv Clin Exp Med; 2024 Apr; 33(4):369-377. PubMed ID: 37540156
[TBL] [Abstract][Full Text] [Related]
4. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.
Scala E; Pallotta S; Frezzolini A; Abeni D; Barbieri C; Sampogna F; De Pità O; Puddu P; Paganelli R; Russo G
Clin Exp Immunol; 2004 Dec; 138(3):540-6. PubMed ID: 15544634
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
[TBL] [Abstract][Full Text] [Related]
7. Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
Seki N; Tsujimoto H; Tanemura S; Ishigaki S; Takei H; Sugahara K; Yoshimoto K; Akiyama M; Kaneko Y; Chiba K; Takeuchi T
Cytokine; 2024 Apr; 176():156534. PubMed ID: 38354516
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.
Gourh P; Agarwal SK; Divecha D; Assassi S; Paz G; Arora-Singh RK; Reveille JD; Shete S; Mayes MD; Arnett FC; Tan FK
Arthritis Rheum; 2009 Dec; 60(12):3794-806. PubMed ID: 19950257
[TBL] [Abstract][Full Text] [Related]
9. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
Tang J; Lei L; Pan J; Zhao C; Wen J
Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound.
Schiopu E; Au KM; McMahon MA; Kaplan MJ; Divekar A; Singh RR; Furst DE; Clements PJ; Ragvendra N; Zhao W; Maranian P; Khanna D
Rheumatology (Oxford); 2014 Apr; 53(4):704-13. PubMed ID: 24357811
[TBL] [Abstract][Full Text] [Related]
11. Relationships between IL-1β, TNF-α genetic polymorphisms and HBV infection: A meta-analytical study.
Wei Y; Zhao Z; Wang Z; Zhang K; Tang Z; Tao C
Gene; 2021 Jul; 791():145617. PubMed ID: 33775848
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Innate and Acquired Immune Responses in Systemic Sclerosis Primary Peripheral Blood Mononuclear Cells (PBMCs).
Szabo I; Badii M; Gaál IO; Szabo R; Popp RA; Joosten LAB; Crişan TO; Rednic S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833885
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and adipokines/cytokines dysregulation in systemic sclerosis.
Iannone F; Praino E; Rotondo C; Natuzzi D; Bizzoca R; Lacarpia N; Fornaro M; Cacciapaglia F
Clin Exp Immunol; 2021 Nov; 206(2):153-160. PubMed ID: 34358345
[TBL] [Abstract][Full Text] [Related]
14. The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis.
Zhou Y; Hou W; Xu K; Han D; Jiang C; Mou K; Li Y; Meng L; Lu S
Hum Immunol; 2015 Jan; 76(1):22-9. PubMed ID: 25500255
[TBL] [Abstract][Full Text] [Related]
15. Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels.
Vettori S; Cuomo G; Iudici M; D'Abrosca V; Giacco V; Barra G; De Palma R; Valentini G
J Clin Immunol; 2014 Aug; 34(6):663-8. PubMed ID: 24760110
[TBL] [Abstract][Full Text] [Related]
16. Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis.
Sakamoto N; Kakugawa T; Hara A; Nakashima S; Yura H; Harada T; Ishimoto H; Yatera K; Kuwatsuka Y; Hara T; Ichinose K; Obase Y; Ishimatsu Y; Kohno S; Mukae H
Respir Res; 2015 Dec; 16():148. PubMed ID: 26654954
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.
Schmidt K; Martinez-Gamboa L; Meier S; Witt C; Meisel C; Hanitsch LG; Becker MO; Huscher D; Burmester GR; Riemekasten G
Arthritis Res Ther; 2009; 11(4):R111. PubMed ID: 19615053
[TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.
Sato S; Hasegawa M; Takehara K
J Dermatol Sci; 2001 Oct; 27(2):140-6. PubMed ID: 11532378
[TBL] [Abstract][Full Text] [Related]
20. Interleukin (IL)-17F and IL-17E are related to fibrosis and vasculopathy in systemic sclerosis.
Fukayama M; Yoshizaki A; Fukasawa T; Ebata S; Kuzumi A; Yoshizaki-Ogawa A; Asano Y; Oba K; Sato S
J Dermatol; 2020 Nov; 47(11):1287-1292. PubMed ID: 32686186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
